Here’s what you should know:
1. Henry Schein’s sales increased 10.3 percent, year-over-year.
2. Henry Schein reported net income of $138 million for the third quarter, which was up 3.2 percent from the same period last year.
3. The company’s medical division saw $690.8 million in sales, which was an 8 percent increase year-over-year. Henry Schein’s dental division was still its most profitable with sales of $1.5 billion in the third quarter.
4. Henry Schein’s CEO Stanley Bergman said in a release, “Solid overall sales results for the quarter reflect continued success with our comprehensive offering of products and value-added services that drive internal growth, complemented by strategic acquisitions.”
5. Through the first three quarters of 2017, Henry Schein posted $9.1 billion in sales. Concerning end-of-year outlooks, Henry Schein expects to post earnings between $3.46 and $3.48 earnings per share.
More articles on transactions/valuations:
Wilford Eye Center unites eye surgery departments — 4 insights
6 recent ASC acquisitions & partnerships — October 2017
3 trends gaining traction in ASC valuations heading into 2018
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
